Detalhe da pesquisa
1.
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC.
Ann Oncol
; 34(4): 377-388, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709038
2.
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis.
Ann Oncol
; 31(11): 1536-1544, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861806
3.
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.
Ann Oncol
; 31(4): 517-524, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32151507
4.
Overview of current systemic management of EGFR-mutant NSCLC.
Ann Oncol
; 29(suppl_1): i3-i9, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462253
5.
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 34(4): 339-357, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872130
6.
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 34(4): 358-376, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36669645
7.
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer.
Ann Oncol
; 29(9): 1964-1971, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010763
8.
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Ann Oncol
; 28(11): 2698-2706, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045553
9.
Testing for COVID-19 in lung cancer patients.
Ann Oncol
; 31(7): 832-834, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32278879
10.
Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".
Ann Oncol
; 30(5): 863-870, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987360
11.
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer.
Ann Oncol
; 25(8): 1578-84, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24827127
12.
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv192-iv237, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285222
13.
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.
Ann Oncol
; 22(9): 2057-2067, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321086
14.
Differences Between the East and the West in Managing Advanced-Stage Non-small Cell Lung Cancer.
Clin Oncol (R Coll Radiol)
; 32(1): e1-e9, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375307
15.
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Breast Cancer Res Treat
; 113(3): 529-35, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18327706
16.
A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
Integr Cancer Ther
; 18: 1534735419836501, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905173
17.
Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis.
Eur Respir J
; 32(4): 911-23, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18508827
18.
The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis.
Clin Oncol (R Coll Radiol)
; 29(9): 568-575, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28499791
19.
Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
Clin Cancer Res
; 5(7): 1676-81, 1999 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10430068
20.
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong.
Hong Kong Med J
; 16 Suppl 3: 34-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20601732